Last Updated:
Access Report
Name Designation Appointment Date Status
Kozhappilly Narayanan Kutty

Appointed as Director since May 2024

 Director 10-May-2024 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Raghunath Kolayambarampath

Appointed as Whole-time director since April 2014

 Whole-time director 05-Apr-2014 Current

People Timeline

Explore the timeline of key personnel in Xander Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address 2/530 C-D-E, Anamangad P.O., Perinthalmanna, Malappuram, Perintalmanna Kerala, 679357, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 679357
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Xander Pharmaceuticals Private Limited?
You can contact Xander Pharmaceuticals Private Limited through their registered address at 2/530 C-D-E, Anamangad P.O., Perinthalmanna, Malappuram, Perintalmanna Kerala, 679357, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Xander Pharmaceuticals Private Limited?
The current directors of Xander Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • KOZHAPPILLY NARAYANAN KUTTY
  • RAGHUNATH KOLAYAMBARAMPATH
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available